首页> 外文期刊>Quality of Life Research >Facets of physical function assessed by patient-reported outcome measures in oncology research
【24h】

Facets of physical function assessed by patient-reported outcome measures in oncology research

机译:

获取原文
获取原文并翻译 | 示例

摘要

The U.S. Food Drug Administration has identified physical functioning (PF) as a core patient-reported outcome (PRO) in cancer clinical trials. The purpose of this study was to identify PF PRO measures (PROMs) in adult cancer populations and classify the PROMs by content covered (facets of PF) in each measure.As part of the Patient Reports of Physical Functioning Study (PROPS) research program, we conducted a targeted literature review to identify PROMs that could be used in clinical trials to evaluate PF from the patient perspective. Next, we convened an advisory panel to conduct a modified, reactive, Delphi study to reach consensus on which PF facets are assessed by PROMs identified in the review. The panel engaged in a “card sort” activity to classify PROM items by PF facets. Consensus was reached when 80 of panel members agreed that at least one facet was being measured by each PROM item.The literature review identified 13 PROMs that met inclusion criteria. Eight facets of PF were identified for classification in the Delphi study: ability, completion, difficulty, limitation, quality, frequency, bother, and satisfaction. Through two rounds, the panel documented and classified conceptual approaches for each PRO item presented. The most prevalent PF facets were ability, difficulty, and limitation.Classifying PF PROMs by PF facets will promote more consistent communication regarding the aspects of PF represented in each PROM, helping researchers prioritize measures for inclusion in cancer clinical trials.

著录项

  • 来源
    《Quality of Life Research》 |2024年第7期|1819-1828|共10页
  • 作者单位

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    AstraZeneca, Evinova, Durham, USA;

    Medical Center Library, Duke University School of Medicine, Durham, USA;

    Department of Surgery, Duke University School of Medicine, Durham, USA;

    Department of Neurosurgery, Duke University School of Medicine, Durham, USA;

    Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, USA;

    Oncology Center of Excellence (OCE), U.S. Food and Drug Administration, Washington D.C., USA;

    Oncology Center of Excellence (OCE), U.S. Food and Drug Administration, Washington D.C., USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

    Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号